Abstract
Much of this review course is directed towards reviewing of ‘New Concepts in Pharmacokinetics and Pharmacodynamics’ and their application for the New Millennium. Thus this review will simply highlight some of these issues which will be discussed in greater detail in subsequent chapters. Most of the pharmacokinetic (and pharmacodynamic) principles that guide the administration of intravenous and volatile anesthetics are very similar. I will concentrate on the development of newer principles for intravenous anesthetics, but many of these are equally applicable to the volatile anesthetics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schwilden H, Stoekel H, Schuttler J: Closed-loop feedback control of propofol anaesthesia by quantitative EEG analysis in humans. Br J Anaesth 62: 290–296, 1989
Schwilden H, Schüttler J, Stoekel H: Closed-loop feedback control of methohexital anesthesia by quantitative EEG analysis in humans. Anesthesiology 67: 341, 1987
Struys M, Smet T, Audenaert S, Versichelen L, Mortier E, Roily G: Development of a closed loop system for propofol using bispectral analysis and a patient-individual pharmacokinetic-dynamic (PK-PD) model. Preliminary results. Brit J of Anaesthesia 78Suppl 1: 23, Abs A.76, 1997
Kenny GNC, Davies FW, Mantzardis H, Fisher AC: Closed-loop control of anesthesia. Anesthesiology 77((3)): A328, 1992
Kruger-Thiemer E: Continuous intravenous infusion and multicompartment accumulation. Eur J Pharmacol 4: 317–324, 1968
Schwilden H: A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol 20: 379–386, 1981
Schwilden H, Schuttler J, Stoekel H: Pharmacokinetics as applied to total intravenous anaesthesia: theoretical considerations. Anaesthesia 38((suppl)): 51–52, 1983
Schwilden H, Stoekel H, Schuttler J, Lauven PM: Pharmacological models and their use in clinical anaesthesia. Eur J Anaesth 3: 175–208, 1986
Schüttler J, Schwilden H, Stoekel H: Pharmacokinetics as applied to total intravenous anaesthesia: practical implications. Anaesthesia 38((suppl)): 53–56, 1983
Glass PSA, Shafer SL, Jacobs JR, Reves JG: Intravenous drug delivery systems, Anesthesia. Edited by Miller R. New York, NY, Churchill Livingstone, 1994, pp 389–416
Servin FS: TCI compared with manually controlled infusion of propofol: a multi-center study. Anaesthesia 53(Supplement 1): 82–6, 1998
Raemer DB, Buschman A, Johnson MD: Alfentanil pharmacokinetic model applied to ambulatory surgical patients: does a computerized infusion improve predictability? Anesthesiology 69: A243, 1988
Raemer DB, Buschman A, Varve JR: The prospective use of population pharmacokinetics in a computer-driven infusion system for alfentanil. Anesthesiology 73: 66, 1990
Glass PSA, Goodman DK, Ginsberg B, Reves JG, Jacobs JR: Accuracy of pharmacokinetic model-driven infusion of propofol. Anesthesiology 71(3A): A277, 1989
Coetzee JF, Glen JB, Wium CA, Boshoff L: Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. Anesthesiology 82(6): 1328–45, 1995
Shafer SL, Varvel JR, Aziz N, Scott JC: The pharmacokinetics of fentanyl administered by computer controlled infusion pump. Anesthesiology 73: 1091–1102, 1990
Ausems ME, Stanski DR, Hug CC: An evaluation of the accuracy of pharmacokinetic data for the computer assisted infusion of alfentanil. Br J Anaesth 57: 1217–1225, 1985
McClain DA, Hug CC, Jr.: Intravenous fentanyl kinetics. Clin Pharmacol Ther 28: 106, 1980
Maitre PE, Stanski DR: Bayesian forecasting improves the prediction of intraoperative plasma concentrations of alfentanil. Anesthesiology 69: 652–659, 1988
Minto CF, Schnider TW, Egan TD, et al.: The influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology, 1997
Bailey JM, Mora CT, Shafer SL: Multicenter study of perioperative ischemia research group: Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. Anesthesiology 81: 1288–97, 1996
Fiset P, Mathers L, Engstrom R, Fitzgerald D, Brand SC, Hsu F, Shafer SL: Pharmacokinetics of computer controlled alfentanil administration in children undergoing cardiac surgery. Anesthesiology 83: 944–55, 1995
Shafer SL, Varvel JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 74: 53–63, 1991
Hughes MA, Glass PSA, Jacobs JR: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 76: 334–341, 1992
Vuyk J, Mertens MJ, Olofsen E, Burm AGL, Bovill JG: Propofol Anesthesia and rational opioid selection. Anesthesiology 87: 1549–62, 1997
Ginsberg B, Howell S, Glass PSA, Margolis JO, Ross AK, Dear GL, Shafer SL: Pharmacokinetic model-driven infusion of fentanyl in children. Anesthesiology 85: 1268–1275, 1996
Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J: Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharm Ther 25: 358–371, 1979
Shafer SL, Gregg K: Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer controlled infusion pump. J Pharmacokinet Biopharm 20: 147–169, 1992
Jacobs JR, Williams EA: Algorithm to control “effect compartment” drug concentrations in pharmacokinetic model-driven drug delivery. IEEE Trans Biomed Eng 40((10)): 993–999, 1993
Ausems ME, Hug CC, Jr., Stanski DR, Burm AGL: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 65: 362–373, 1986
Glass PSA, Doherty M, Jacobs JR, Goodman D, Smith LR: Plasma concentration of fentanyl, with 70% nitrous oxide, to prevent movement at skin incision. Anesthesiology 78: 842–847, 1993
Vuyk J, Engbers FHM, Lemmens HJM, Burm AGL, Vletter AA, Gladines MPRR, Bovill JG: Pharmacodynamics of propofol in female patients. Anesthesiology 77: 3–9, 1992
Scott JC, Ponganis KV, Stanski DR: EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 62: 234–241, 1985
Scott JC, Cooke JE, Stanski DR: Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 74: 34, 1991
Egan TD, Lemmens HJM, Fiset P, Muir KT, Hermann D, Stanski DR, Shafer S: The pharmacokinetics and pharmacodynamics of GI 87084B. Anesthesiology 77(3): A369, 1992
Egan TD, Lemmens MH, Fiset P, Stanski DR, Shafer S: Pharmacokinetic-dynamic fingerprinting in the early development of GI87084B. Clin Pharmacol Ther 53(2): 209, 1993
Glass PSA, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B). Anesth & Analg 77: 1031–40, 1993
Vuyk J, Lim T, Engbers FHM, Burm AGL, Vletter AA, Bovill JG: The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in female patients. Anesthesiology 83: 8–22, 1995
Smith C, McEwan AI, Jhaveri R, Wilkinson M, Goodman D, Canada A, Glass PSA: Reduction of propofol Cp50 by fentanyl. Anesthesiology 77(3a): A340, 1992
Katoh T, Ikeda I: The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology 88: 18–24, 1998
Brunner MD, Braithwaite P, Jhaveri R, McEwan AI, Goodman DK, Smith LR, Glass PSA: The MAC reduction of isoflurane by sufentanil. Br J Anaesth 72: 42–46, 1994
Lang E, Kapila A, et al.: The reduction of the MAC of isoflurane by remifentanil. Anesthesiology 85: 721–728, 1996
McEwan AI, Smith C, Dyar O, Goodman D, Glass PSA: Isoflurane MAC reduction by fentanyl. Anesthesiology 78: 864–869, 1993
Sebel PS, Glass PSA, Fletcher JE, Murphy MR, Gallagher C, Quill T: Reduction of the MAC of desflurane with fentanyl. Anesthesiology 76: 52–59, 1992
Westmoreland C, Sebel PS, Groper A, Hug CC, Jr.: Reduction of isoflurane MAC by fentanyl or alfentanil. Anesthesiology 77((3)): A394, 1992
Gan TJ, Glass PS, Windsor A, Payne F, Rosow C, Sebel P, Manberg P: Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. Anesthesiology 87: 808–815, 1997
Glass PSA, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P: Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and Alfentanil in healthy volunteers. Anesthesiology 86: 836–47, 1997
Lui J, Singh H, White PF: Electroencephalograph bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology 84: 64–9, 1996
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Glass, P.S.A. (1999). New Pharmacokinetic Concepts. In: Stanley, T.H., Egan, T.D. (eds) Anesthesia for the New Millennium. Developments in Critical Care Medicine and Anesthesiology, vol 34. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4566-4_1
Download citation
DOI: https://doi.org/10.1007/978-94-011-4566-4_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5935-0
Online ISBN: 978-94-011-4566-4
eBook Packages: Springer Book Archive